Академический Документы
Профессиональный Документы
Культура Документы
LAYOUT
Case History Investigation Diagnosis Glaucoma Pathophysiology
Features
Management
PATIENTS PROFILE
Name: XYZ Age:25 Years Sex: Female Residence: Rawalpindi Occupation: Housewife Date Of History Taking: 17 January ,2011
hopi
HOPI
Past history
Asthma DM negative HTN No H/O any medical or surgical intervention
Examination
negative
DIAGNOSIS
A diagnosis of Uncomplicated UTI was made
TREATMENT
Septran (Co-Trimoxazole)
UTI
Definition: .
IOP
TYPES OF GLAUCOMA
Level of intraocular pressure Increasing age African-Caribbean origin Family history Thin corneas
Trabecular meshwork
Ant chamber
PATHOPHYSIOLOGY
CONSEQUENCES
Increased IOP
MANAGEMENT
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Vivamus et magna. Fusce sed sem sed magna suscipit egestas. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Vivamus et magna. Fusce sed sem sed magna suscipit egestas.
ACETAZOLAMIDE
Structure and Chemistry
Sulfonamide derivative synthetic origin.
PHARMACOKINETICS
Route of administration: Oral Absorption: Well Absorbed Bioavailability: 100% Distribution: High Conc. In CA Rich tissues Metabolism: not metabolized Half life: 6-9 Hours
SITE OF ACTION
Acetazolamide
PHARMACODYNAMICS
Site of action
Carbonic Anhydrase in
PCT (Membrane
bound & Cytoplasmic)
MECHANISM OF ACTION
Acts as an inhibitor of
Carbonic Anhydrase
PHARMACOLOGICAL ACTIONS
EFFECTS ON KIDNEY
HCO3
Urine
CA In PCT
Blood
Metabolic Acidosis
Na+ In CCT Excess Na+ Reabsorbed; K+ Secreted
K+ Wasting
EFFECTS ON EYE
HCO3
Blood
CA In Ciliary Epithelium
Aqueous humour
Acetazolamide Administration
Decreased I.O.P
EFFECTS ON CSF
HCO3
Blood
CA In Choroid plexus
Blood
Acetazolamide administered
Decreased HCO3 Secretion into CSF Acidosis of CNS Promotes Hyperventilation
CLINICAL INDICATIONS
CLINICAL INDICATIONS(CONTD.)
Weakness
Dizziness
Death
Insomnia
Mild
Headache
Nausea
OTHER USES
Epilepsy Adjuvant
Severe Hyperparathyroidism
FORMULATIONS AVAILABLE
125 mg tablets 250 mg tablets 500 mg sustained release capsules Intravenous injection 500 mg/5 cc No topical formulation of acetazolamide is available (mainly
because of it having a limited aqueous solubility and poor corneal permeation)
THERAPEUTIC DOSAGE
Glaucoma
250 to 1000 mg by mouth daily unable to take oral medicine, 500 mg IV or IM
High-altitude sickness
Metabolic alkalaemia
2.5 to 5 mg per kg body-weight IV
ADVERSE EFFECTS
Renal K+ Wasting
Partially Reabsorbed
K+ Secretion
ADVERSE EFFECTS(Contd.)
Effects Of Acetazolamide
Hypercalciuria
Renal Stones
OTHER TOXICITIES
Drowsiness
CNS Toxicity
Paraesthesias
HYPERSENSITIVITY REACTIONS
Fever
CONTR-INDICATIONS
In pts. Of Cirrhosis
ACZ
Alk. Urine
NH4+ Excretion
DRUG-DRUG INTERACTIONS
folic acid antagonists, oral hypoglycemic agents and oral anticoagulants
Effects
Salicylates risk of Acetazolamides side effects Primidone, salicylates (e.g., aspirin), lithium, or methenamine their effectiveness may be by Acetazolamide
Any Questions???
Your eyes are the gateway to world, save them.